James C. Sisson
#165,434
Most Influential Person Now
James C. Sisson's AcademicInfluence.com Rankings
James C. Sissonengineering Degrees
Engineering
#7298
World Rank
#8664
Historical Rank
Biomedical Engineering
#728
World Rank
#740
Historical Rank
James C. Sissonphilosophy Degrees
Philosophy
#9719
World Rank
#13319
Historical Rank
Logic
#6686
World Rank
#8229
Historical Rank
Download Badge
Engineering Philosophy
James C. Sisson's Degrees
- PhD Biomedical Engineering Stanford University
- Doctorate Medicine Stanford University
Why Is James C. Sisson Influential?
(Suggest an Edit or Addition)James C. Sisson's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Scintigraphic localization of pheochromocytoma. (1981) (534)
- Iodine-131 metaiodobenzylguanidine for the locating of suspected pheochromocytoma: experience in 400 cases. (1985) (361)
- Metaiodobenzylguanidine to map scintigraphically the adrenergic nervous system in man. (1987) (311)
- Metaiodobenzylguanidine as an index of the adrenergic nervous system integrity and function. (1987) (310)
- Pheochromocytomas: imaging with 2-[fluorine-18]fluoro-2-deoxy-D-glucose PET. (1999) (308)
- Prognostic Implications of the Tall Cell Variant of Papillary Thyroid Carcinoma (1988) (265)
- Effect of uptake-one inhibitors on the uptake of norepinephrine and metaiodobenzylguanidine. (1985) (253)
- The normal and abnormal distribution of the adrenomedullary imaging agent m-[I-131]iodobenzylguanidine (I-131 MIBG) in man: evaluation by scintigraphy. (1983) (243)
- QT interval prolongation and sudden cardiac death in diabetic autonomic neuropathy. (1987) (227)
- Radiopharmaceutical treatment of malignant pheochromocytoma. (1984) (213)
- Radiation safety in the treatment of patients with thyroid diseases by radioiodine 131I : practice recommendations of the American Thyroid Association. (2011) (185)
- Radio-iodobenzylguanidine for the scintigraphic location and therapy of adrenergic tumors. (1985) (166)
- PET scanning with hydroxyephedrine: an approach to the localization of pheochromocytoma. (1992) (163)
- Comparison of the sodium dependency of uptake of meta-lodobenzylguanidine and norepinephrine into cultured bovine adrenomedullary cells. (1984) (162)
- Neuroblastoma: positron emission tomography with 2-[fluorine-18]-fluoro-2-deoxy-D-glucose compared with metaiodobenzylguanidine scintigraphy. (1996) (153)
- Labetalol reduces iodine-131 MIBG uptake by pheochromocytoma and normal tissues. (1989) (141)
- Pilot study of iodine-131-metaiodobenzylguanidine in combination with myeloablative chemotherapy and autologous stem-cell support for the treatment of neuroblastoma. (2002) (129)
- Spectrum of pheochromocytoma in multiple endocrine neoplasia. A scintigraphic portrayal using 131I-metaiodobenzylguanidine. (1981) (127)
- Uptake of 18-fluoro-2-deoxy-D-glucose by thyroid cancer: implications for diagnosis and therapy. (1993) (124)
- MALIGNANT PHAEOCHROMOCYTOMA: CLINICAL, BIOCHEMICAL AND SCINTIGRAPHIC CHARACTERIZATION (1984) (123)
- Immunohistochemical localization of epinephrine, norepinephrine, catecholamine-synthesizing enzymes, and chromogranin in neuroendocrine cells and tumors. (1986) (117)
- Inverse relationship between cardiac accumulation of meta-[131I]iodobenzylguanidine (I-131 MIBG) and circulating catecholamines in suspected pheochromocytoma. (1983) (116)
- A phase II study of imatinib in patients with advanced anaplastic thyroid cancer. (2010) (111)
- Biochemical Diagnosis and Localization of Pheochromocytoma (2006) (103)
- Iodine-131 MIBG scintigraphy of neuroendocrine tumors other than pheochromocytoma and neuroblastoma. (1987) (103)
- Complementary roles of CT and 131I-MIBG scintigraphy in diagnosing pheochromocytoma. (1983) (95)
- Specificity of radioiodinated MIBG for neural crest tumors in childhood. (1997) (95)
- Iodine-131 metaiodobenzylguanidine scintigraphy for the location of neuroblastoma: preliminary experience in ten cases. (1985) (94)
- Treatment of malignant pheochromocytomas with 131-I metaiodobenzylguanidine and chemotherapy. (1999) (89)
- Calcitonin, carcinoembryonic antigen and neuron‐specific enolase in medullary thyroid carcinoma. An immunohistochemical study (1983) (88)
- PET hydroxyephedrine imaging of neuroblastoma. (1996) (87)
- Pheochromocytoma and the normal adrenal medulla: improved visualization with I-123 MIBG scintigraphy. (1985) (87)
- Linkage of the multiple endocrine neoplasia type 2B gene (MEN2B) to chromosome 10 markers linked to MEN2A. (1990) (84)
- Thyrotoxicosis caused by thyroid cancer. (1990) (82)
- Nuclear medicine imaging of pheochromocytoma and neuroblastoma. (1999) (82)
- The location of middle mediastinal pheochromocytomas. (1984) (82)
- Sodium dependency of uptake of norepinephrine and m-iodobenzylguanidine into cultured human pheochromocytoma cells: evidence for uptake-one. (1987) (81)
- Iodine-131: optimal therapy for hyperthyroidism in children and adolescents? (1979) (78)
- Plasma catecholamines in pheochromocytoma: effect of urographic contrast media. (1984) (77)
- Is preoperative iodine 123 meta-iodobenzylguanidine scintigraphy routinely necessary before initial adrenalectomy for pheochromocytoma? (2003) (76)
- Metabolism of iodine-131 metaiodobenzylguanidine in patients with metastatic pheochromocytoma. (1986) (75)
- Portrayal of pheochromocytoma and normal human adrenal medulla by m-[123I]iodobenzylguanidine: concise communication. (1984) (75)
- Clinical decision analysis. The hazard of using additional data. (1976) (71)
- 131‐I treatment of micronodular pulmonary metastases from papillary thyroid carcinoma (1996) (69)
- The spectrum of pheochromocytoma in hypertensive patients with neurofibromatosis. (1982) (69)
- Radiopharmaceutical therapy of malignant pheochromocytoma with [131I]metaiodobenzylguanidine: results from ten years of experience. (1991) (69)
- The so-called stunning of thyroid tissue. (2006) (66)
- Scintigraphic detection of regional disruption of adrenergic neurons in the heart. (1988) (66)
- Differentiated Thyroid Carcinomas: Treatment of Distant Metastases (1974) (64)
- Iodine-123-MIBG imaging of neuroblastoma: utility of SPECT and delayed imaging. (1996) (61)
- Staging of differentiated thyroid carcinoma using diagnostic 131I SPECT/CT. (2010) (59)
- Small cell tumors of the thyroid A clinicopathologic study (1971) (58)
- Variation in the management of thyroid cancer. (2013) (57)
- Thyroid carcinoma: Clinical practice guidelines (2005) (57)
- Prediction of sudden cardiac death in diabetic autonomic neuropathy. (1988) (56)
- Plasma 3,4-dihydroxyphenylalanine (dopa) and catecholamines in neuroblastoma or pheochromocytoma. (1986) (56)
- Pretibial myxedema and nonthyrotoxic thyroid disease. (1973) (55)
- Orbital radiation for the ocular changes of Gravess' disease. (1975) (55)
- Increasing efficacy and safety of treatments of patients with well-differentiated thyroid carcinoma by measuring body retentions of 131I. (2003) (55)
- Treatment of malignant pheochromocytoma with a new radiopharmaceutical. (1983) (54)
- Surgical treatment of cardiac pheochromocytomas. (1985) (54)
- Choroidal and skin metastases from papillary thyroid cancer: case and a review of the literature. (2004) (54)
- Current Trends in Functional Imaging of Pheochromocytomas and Paragangliomas (2006) (54)
- Diagnostic accuracy and pitfalls of [iodine-131]6-beta-iodomethyl-19-norcholesterol (NP-59) imaging. (1990) (54)
- Primary Extra-Adrenal Pheochromocytoma Positive I-123 MIBG Imaging with Negative I-131 MIBG Imaging (1986) (53)
- Follicular carcinoma of the thyroid with massive angioinvasion: extension of tumor thrombus to the heart. (1978) (52)
- Thyroid carcinoma. (2005) (51)
- Detection of HLA-DR antigens in paraffin-embedded thyroid epithelial cells with a monoclonal antibody. (1985) (50)
- Salivary gland accumulation of meta-[131I]iodobenzylguanidine. (1984) (49)
- Iodine-125-MIBG to treat neuroblastoma: preliminary report. (1990) (47)
- Principles of, and pitfalls in, thyroid function tests. (1965) (46)
- 131‐I‐Metaiodobenzylguanidine Treatment in Patients with Refractory Advanced Neuroblastoma (1992) (45)
- Applying the radioactive eraser: I-131 to ablate normal thyroid tissue in patients from whom thyroid cancer has been resected. (1983) (45)
- Radiopharmaceutical Treatment of Pheochromocytomas (2002) (43)
- The current status of meta-iodobenzylguanidine and related agents for the diagnosis of neuro-endocrine tumors. (1995) (43)
- An immunohistochemical study of pheochromocytomas. (1984) (42)
- Radiolabeled meta-iodobenzylguanidine: pharmacology and clinical studies. (1986) (41)
- Familial medullary thyroid carcinoma associated with cutaneous lichen amyloidosis. (2009) (40)
- Intralesional triamcinolone therapy for pretibial myxedema. (1975) (38)
- SEQUESTERED NODULAR GOITER. (1964) (37)
- Cardiac paragangliomas: A clinicopathologic and immunohistochemical study of four cases (1985) (36)
- Conjugate view gamma camera method for estimating tumor uptake of iodine-131 metaiodobenzylguanidine. (1988) (35)
- Theranostics: evolution of the radiopharmaceutical meta-iodobenzylguanidine in endocrine tumors. (2012) (35)
- Thyroid carcinoma metastasis to skull with infringement of brain: treatment with radioiodine. (2009) (34)
- Long-term results of [131I]metaiodobenzylguanidine treatment of refractory advanced neuroblastoma. (1991) (34)
- Procedure guideline for parathyroid scintigraphy (1998) (33)
- Survival of patients with neuroblastoma treated with 125-I MIBG. (1996) (33)
- Phaeochromocytoma and functioning paraganglioma in childhood and adolescence: role of iodine 131 metaiodobenzylguanidine (1991) (32)
- Unusual complications of antithyroid drug therapy: four case reports and review of literature. (1989) (31)
- Use of 2-[F-18]-fluoro-2-deoxy-D-glucose PET to locate parathyroid adenomas in primary hyperparathyroidism. (1994) (30)
- Familial extra-adrenal pheochromocytoma. A new syndrome. (1985) (30)
- The dilemma of the solitary thyroid nodule: resolution through decision analysis. (1978) (30)
- Hyaluronic acid in localized myxedema. (1968) (29)
- Measuring acute changes in adrenergic nerve activity of the heart in the living animal. (1991) (29)
- Predictors of toxicity in treating patients with neuroblastoma by radiolabeled metaiodobenzylguanidine (2004) (28)
- Dilemmas in the early diagnosis and treatment of multiple endocrine adenomatosis, type II. (1977) (27)
- Practical dosimetry of 131I in patients with thyroid carcinoma. (2002) (26)
- Treatment of micronodular lung metastases of papillary thyroid cancer: are the tumors too small for effective irradiation from radioiodine? (1998) (25)
- Determination of iodine-131 diagnostic dose for imaging metastatic thyroid cancer. (1986) (25)
- 131I-MIBG--a new agent in diagnosis and treatment of pheochromocytoma. (1985) (24)
- Cryptococcal thyroiditis and hyperthyroidism. (2004) (24)
- Factors that influence radioactive iodine use for thyroid cancer. (2013) (24)
- Ectopic thyroid tissue in the neck. Benign or malignant? (1976) (24)
- The effects of lymphocytes, sera, and long-acting thyroid stimulator from patients with Graves' disease on retrobulbar fibroblasts. (1973) (24)
- 99mTc-pyrophosphate scan and radiographic correlation in thyroid acropachy: case report. (1976) (24)
- Iodine-123-4-amino-3-iodobenzylguanidine, a new sympathoadrenal imaging agent: comparison with iodine-123 metaiodobenzylguanidine. (1986) (23)
- Early diagnosis and thyroidectomy in multiple endocrine neoplasia, type 2b. (1983) (23)
- Thyroid carcinoma with high levels of function: treatment with (131)I. (2001) (23)
- Medical treatment of benign and malignant thyroid tumors. (1989) (22)
- Perspective: The Case Against Radioiodine Remnant Ablation in Patients with Well-Differentiated Thyroid Carcinoma (2008) (22)
- Pheochromocytoma, polycythemia, and venous thrombosis. (1987) (21)
- Recurrent medullary carcinoma of the thyroid demonstrated by thallium-201 scintigraphy. (1986) (20)
- Courses of Malignant Pheochromocytoma (2006) (20)
- Thyroid function following neck irradiation for malignant lymphoma. (1980) (20)
- Iodine-131 MIBG scintigraphy of the extremities in metastatic pheochromocytoma and neuroblastoma. (1987) (20)
- Scintigraphy with I-131 MIBG as an aid to the treatment of pheochromocytomas in patients with the multiple endocrine neoplasia type 2 syndromes. (1984) (19)
- Connective tissue activation. XVIII. Stimulation of hyaluronic acid synthetase activity. (1980) (19)
- Toxicity from treatment of neuroblastoma with 131I-meta-iodobenzylguanidine (2004) (19)
- Limitations of 131I-MIBG scintigraphy in locating pheochromocytomas. (1985) (18)
- Lymphocyte-retrobulbar fibroblast interaction: mechanisms by which stimulation occurs and inhibition of stimulation. (1972) (18)
- MR Imaging of the Thyroid: Comparison with Scintigraphy in the Normal and Diseased Gland (1987) (18)
- Locating neuroblastoma in the opsoclonus-myoclonus syndrome. (1994) (18)
- Alterations of iodine-131 MIBG biodistribution in an anephric patient: comparison to normal and impaired renal function. (1989) (18)
- Scintigraphic portrayal of beta receptors in the heart. (1991) (17)
- Radioiodine Therapy and Graves' Ophthalmopathy (2008) (17)
- Adrenocortical SPECT using iodine-131 NP-59. (1998) (17)
- Treatment of neuroblastoma with [125I]metaiodobenzylguanidine. (1991) (16)
- Gastrointestinal iodine-131-meta-iodobenzylguanidine activity. (1988) (16)
- Radioiodine treatment of hyperthyroidism: fixed or calculated doses; intelligent design or science? (2007) (16)
- Appearance of ectopic undescended inferior parathyroid adenomas on technetium Tc 99m sestamibi scintigraphy: a lesson from reoperative parathyroidectomy. (2003) (15)
- Stimulation of glucose utilization and glycosaminoglycans production by fibroblasts derived from retrobulbar tissue. (1971) (15)
- Calculating radiation absorbed dose for pheochromocytoma tumors in 131-I MIBG therapy. (1989) (15)
- Selection of the optimal scanning agent for thyroid cancer. (1997) (15)
- Procedure guideline for parathyroid scintigraphy. Society of Nuclear Medicine. (1998) (14)
- What causes uptake of technetium-99m methylene diphosphonate by tumors? A case where the tumor appeared to secrete a hypercalcemia-causing substance. (1985) (14)
- Portrayal of adrenergic denervation in the presence of myocardial infarction: a feasibility study. (1990) (14)
- Radiolabeled meta-iodobenzylguanidine and the adrenergic neurons of salivary glands. (1987) (13)
- Phase II trial evaluating imatinib (I) in patients (pts) with anaplastic thyroid carcinoma (ATC). (2009) (13)
- The current status of radioiodinated metaiodobenzylguanidine therapy of neuro-endocrine tumors. (1995) (13)
- 62 FAMILIAL PARTIAL PERIPHERAL AND PITUITARY RESISTANCE TO THYROID HORMONE - A FREQUENTLY MISSED DIAGNOSIS? (1985) (12)
- Complementary Roles of CT and 131 I-MIBG Scintigraphy in Diagnosing Pheochromocytoma (1984) (12)
- Surgical treatment of thyrotoxicosis in children and adolescents. (1977) (11)
- Extra-adrenal and metastatic pheochromocytoma: The role of131I meta-iodobenzylguanidine (131I MIBG) in localization and management (1984) (11)
- Locating pheochromocytomas by scinTIGraphy using 131i‐metaiodobenzylguanidine (1984) (10)
- Functional aspects of fibroblasts derived from the retrobulbar tissue of man. (1970) (9)
- Three endocrine neoplasms: an unusual combination of pheochromocytoma, pituitary adenoma, and papillary thyroid carcinoma. (2011) (9)
- Hyperthyroidism Associated With Pregnancy (1974) (9)
- Over-the-counter drugs block heart accumulation of MIBG (1985) (9)
- Autoradiography-based, three-dimensional calculation of dose rate for murine, human-tumor xenografts. (1993) (8)
- Referral patterns for patients with high-risk thyroid cancer. (2013) (7)
- Tomographic thyroid scintigraphy: comparison with standard pinhole imaging: concise communication. (1981) (7)
- EFFECT OF THYROIDECTOMY WITH AND WITHOUT THYROXINE REPLACEMENT ON TRANSPLANTABLE THYROID TUMORS IN RATS. (1964) (7)
- Serum thyroglobulin levels after thyroxine withdrawal in patients with low risk papillary thyroid carcinoma. (2000) (7)
- The Society of Nuclear Medicine Procedure Guideline For Parathyroid Scintigraphy (2004) (7)
- Mechanisms of uptake of norepinephrine (NE) and Meta-iodobenzylguanidine (MIBG) into cultured bovine adrenomedullary cells: Evidence for uptake-one (1984) (7)
- Scintigraphic Portrayal of the Syndrome of Multiple Endocrine Neoplasia Type-2B (1988) (7)
- Diagnosis of adrenal tumors with radionuclide imaging. (1984) (7)
- Acid mucopolysaccharide alterations in experimental exophthalmos. (1967) (7)
- Staging of Differentiated Thyroid Carcinoma Using Diagnostic (2010) (6)
- First Description of Parathyroid Disease in Multiple Endocrine Neoplasia 2A Syndrome (2008) (6)
- What promise the preliminary tests of coronary artery disease? (1981) (6)
- Proceedings: Differentiated thyroid carcinomas. Treatment of distant metastases. (1974) (6)
- Iodine-125-MIBG Therapy for Neuroblastoma—Reply (1991) (6)
- Clonidine-induced suppression of plasma catecholamines in states of adrenal medulla hyperfunction (1987) (6)
- Patterns of prolactin secretion in the syndrome of general resistance to thyroid hormones. (1984) (6)
- "Myotonia" of the orbicularis oculi with myxedema. (1962) (5)
- Mechanisms of uptake of norepinephrine (NE) and meta-iodobenzylguanidines (MIBG) into cultured human pheochromocytoma cells (1984) (5)
- Radiopharmaceuticals for nuclear endocrinology at the University of Michigan. (2000) (5)
- Biodistribution and therapeutic effects of radiolabeled metaiodobenzylguanidine in a human neuroblastoma xenograft (1992) (5)
- The role of scintigraphy in the evaluation of fever of unknown origin. (1994) (5)
- Radiation-Induced Osteosarcoma and Papillary Carcinoma of the Thyroid (2006) (5)
- Adrenal gland identification: preoperative assessment. (1982) (5)
- MEN type IIa syndrome: dilemmas in modern management. (1978) (4)
- TSH Binding Inhibition Assay: Prediction and Treatment of Neonatal Graves' Disease (1991) (4)
- Pheochromocytoma, Polycythemia, and Venous Thrombosis (1988) (4)
- Effects of Glucosamine, Dibutyryl Cyclic AMP and Lymphocytes on Retrobulbar Fibroblast Synthesis of Hyaluronic Acid 1 (1977) (4)
- The increasing incidence of thyroid cancer in Saudi Arabia. (1995) (4)
- Simultaneous scintigraphic depiction of aldosteronoma and adrenal infarction. (1996) (4)
- Compressive optic neuropathy in Graves’ eye disease (1983) (4)
- Spectrum of pheochromocytoma in the131I-MIBG era (1988) (4)
- Combining provocative agents of calcitonin to detect medullary carcinoma of the thyroid. (1981) (3)
- Simplified radioimmunoassay for triiodothyronine: evaluation of a new commercial kit. (1976) (3)
- Scintigraphic Imaging of Pheochromocytomas by Means of Metaiodobenzylguanidine (MIBG) (1986) (3)
- Mechanisms by which Retrobulbar Fibroblasts are Stimulated by Lymphocytes: Role of Cyclic Nucleotide (1977) (3)
- Radioiodine therapy of thyrotoxicosis. (1999) (3)
- Pulmonary function in thyroid carcinoma metastatic to the lung (1987) (3)
- Serum protein-bound iodine and resin uptake of triiodothyronine during normal pregnancy. (1967) (3)
- Metabolism of I-131-meta-iodobenzylguanidine (MIBG) in humans (1984) (2)
- /sup 131/I-metaiodobenzylguanidine treatment of malignant pheochromocytomas (1984) (2)
- Inhibition of glycosaminoglycans production in retrobulbar fibroblast cultures by ethacrynic acid and hydrocortisone. (1974) (2)
- Radionuclide therapy for malignancy: influences of physical characteristics of radionuclides and experience with radiolabelled meta-iodobenzylguanidine (1986) (2)
- Bilateral pheochromocytomas (1984) (2)
- Serious reactions to penicillin. (1960) (2)
- Diagnosis and management of hereditary paraganglioma syndrome due to the F933>X67 SDHD mutation (2009) (2)
- Reply: Is the incidence of thyroid cancer increasing is Saudi Arabia? (1996) (1)
- LABELED PLASMA LIPIDS AFTER INGESTION OF RADIOACTIVE FATS. (1965) (1)
- THYROTROPIN AND THE RAT HEMIDIAPHRAGM. (1964) (1)
- Reply: Re: The So-Called Stunning of Thyroid Tissue (2007) (1)
- of the Extremitiesin Metastatic Pheochromocytoma and Neuroblastoma (1987) (1)
- Spectrum of pheochromocytoma in the 131I-MIBG era. (1988) (1)
- RADIOIODINE FOR THYROID CANCER. (1969) (1)
- Response to Beasley CW, Moore WH, and Wagner LK (2011) (1)
- Extra-thyroidal effect of thyrotrophin on serum thyroxine. (1970) (1)
- Reply: Stunning Effect (2007) (1)
- Orbital Radiation in Graves' Disease: Reply (1975) (1)
- Response to Hennessey et al. (2012) (1)
- Radioiodine Therapy of Graves’ Disease (2000) (1)
- The Spectrum of Pheochromocytoma in Hypertensive Patients with Neurofibromatosis (1983) (1)
- Familial Partial Peripheral and Pituitary Resistance to Thyroid Hormone: A Frequently Missed Diagnosis? (1986) (1)
- CLINICAL CASE SEMINAR Choroidal and Skin Metastases from Papillary Thyroid Cancer: Case and a Review of the Literature (2004) (1)
- Reply: A Proposition for the Use of Radioiodine in WDTC Management (2009) (0)
- The character and emphasis of research in nuclear medicine. (1971) (0)
- Society of Nuclear Medicine Procedure Guideline for Parathyroid Scintigraphy version 2 . 0 , approved February 7 , 1999 (2002) (0)
- Early diagnosis and endocrine neoplasia, thyroidectomy type 2b in multiple (1983) (0)
- I-131 therapy of hyperthyroidism in children (1978) (0)
- Salivary Gland Accumulation of Meta-[ (2006) (0)
- SPECT thresholding to determine tumor volumes for dose estimation in radionuclide therapy (2011) (0)
- Alterations of Iodine-13 1 MIBG Biodistribution in an Anephric Patient: Comparison to Normal and Impaired Renal Function (2006) (0)
- Furnace for brazing or welding (1966) (0)
- WhatPromisethePreliminaryTestsof CoronaryArteryDisease? (2006) (0)
- PET Scanningwith Hydroxyephedrine:An Approachto the Localization of Pheochromocytoma (1992) (0)
- TSH Receptor Antibodies in Neonatal Hyperthyroidism (1987) (0)
- THERAPEUTIC NUCLEAR MEDICINE Radiopharmaceutical Treatment of Malignant Pheochromocytoma (2006) (0)
- What is nuclear medicine? (1966) (0)
- Uncertainty in the management of thyroid cancer. (2012) (0)
- Combined pentagastrin-calcium infusion: A new method in diagnosis of medullary carcinoma of the thyroid (MCT) (1978) (0)
- Hyperthyroidism from the additive effect of unsuppressible thyroid hormonogenesis and administered hormone. (1969) (0)
- Contents, Vol. 72, Supplement 1, 1985 (1985) (0)
- Scintigraphic Localization of Pheochromocytoma (1982) (0)
- A simplified radioimmunoassay for triiodothyronine: evaluation of a new commercial kit. (Abstract only) (1975) (0)
- Pathway of norepinephrine uptake: Spectrum in neural tumors (1982) (0)
- Session on the biology and treatment of neuroblastoma as related to metaiodobenzylguanidine. Chairmen's report. (1991) (0)
- Miscellaneous: Effect of phenoxybenzamine on cardiovascular and plasma catecholamine responses to clonidine (1983) (0)
- Familial Extra-Adrenal Pheochromocytoma: A New Syndrome (1985) (0)
- Spectrum of Pheochromocytoma in Multiple Endocrine Neoplasia (2020) (0)
- Allergy to penicillin. (1960) (0)
- Decision Analysis-Reply (1977) (0)
- Re: What Promise the Preliminary Tests of Coronary Artery Disease?—Reply (1982) (0)
- Subject Index, Vol. 72, Supplement 1, 1985 (1985) (0)
- Radio-iodinated MIGB therapy of adrenomedullary tumors (1993) (0)
- Normal HumanAdrenal Medullaby (2006) (0)
- The progressive and diffuse nature of neuroblastoma: Treatment with I-131 metaiodobenzylguanidine (I-131 MIBG). S-W (1985) (0)
- Quantifying Clinical Information: Beyond Physical Diagnosis (1978) (0)
- "Myotonia" of the (2017) (0)
- Drs. Kim et al. reply (1981) (0)
- The crystal ball in the laboratory. (1979) (0)
- Metaiodobenzylguanidine for cardiac and tumor imaging. (1989) (0)
- Thyroid carcinoma. (2007) (0)
- Central neurogenic control of the adrenal medulla in multiple endocrine neoplasia type IIa (1979) (0)
- Postoperative Evaluation of Thyroid Cancer Patients for Adequacy of Surgery and for Need of 131I Therapy (1989) (0)
- Differentiated thyroid carcinomas: treatment of distant metastases. [Long term study of sodium iodine-131 effect after surgery] (1974) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With James C. Sisson?
James C. Sisson is affiliated with the following schools:
